Portage: Cyncado to Focus on Advancing Clinical Development of A2a and A2b Receptor Antagonists to Achieve Proof-of-Concept Data for Its Therapeutics >PRTG

Portage: Cyncado專注於推進A2a和A20億受體拮抗劑的臨牀開發，以實現其治療藥物的概念驗證數據 >PRTG

道瓊斯 · 01/06 18:35

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文

登入/註冊

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。

Portage: Cyncado to Focus on Advancing Clinical Development of A2a and A2b Receptor Antagonists to Achieve Proof-of-Concept Data for Its Therapeutics >PRTG

Portage: Cyncado to Focus on Advancing Clinical Development of A2a and A2b Receptor Antagonists to Achieve Proof-of-Concept Data for Its Therapeutics >PRTG

風險及免責聲明

聲明